SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001191434-17-000002
Filing Date
2017-06-26
Accepted
2017-06-26 16:52:58
Documents
1
Period of Report
2017-04-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 10573
  Complete submission text file 0001191434-17-000002.txt   12005
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Issuer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 999 PONCE DE LEON BLVD., SUITE 625 CORAL GABLES FL 33134
Business Address
Appelrouth Stewart (Reporting) CIK: 0001702626 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-27072 | Film No.: 17930363